References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Vavro (2022) | Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study. | Antimicrob Agents Chemother | PR HIV1 group M: 2 RT HIV1 group M: 5 IN HIV1 group M: 18 |